Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2007
06/13/2007CN1321118C 5-aza-indole preparation method
06/12/2007US7230116 For use as pesticides, microbicides and herbicides
06/12/2007US7230103 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines
06/12/2007US7230102 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments
06/12/2007US7230099 Heterocyclic inhibitors of MEK and methods of use thereof
06/12/2007US7230024 such as 2-(2-chloro-phenyl)-5-isopropyl-3-(3,4,5-trifluoro-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one; for treatment of eating disorders and psychological disorders
06/12/2007US7230008 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
06/12/2007US7230007 Antiarhythmia agents ; cardiovascular disorders; central nervous system disorders
06/12/2007US7230006 For therapy of allergic syndromes
06/12/2007US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
06/12/2007US7229990 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies.
06/12/2007CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors
06/12/2007CA2238410C Novel indole-2,3-dione-3-oxime derivatives
06/12/2007CA2130828C Non-azo naphthalimide dyes and uses for same
06/07/2007WO2007064914A2 5-(arylsulfonyl)-pyrazolopiperidines
06/07/2007WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007WO2007064444A1 Improved method of preparation for imidazolepyridines
06/07/2007WO2007063946A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
06/07/2007WO2007063071A1 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors
06/07/2007WO2007063013A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
06/07/2007WO2007062998A1 3-amino-2-arylpropyl azaindoles and uses thereof
06/07/2007WO2007062996A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/07/2007WO2007047047A3 Polymorph transformation of zolpidem in tablet matrix
06/07/2007WO2007031977A3 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors
06/07/2007WO2007025090A3 Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase
06/07/2007WO2007015877A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders
06/07/2007WO2007015837A3 Inhibitors of checkpoint kinases
06/07/2007WO2007002258A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
06/07/2007WO2006093965A3 Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof
06/07/2007WO2006051413A8 Azabenoxazoles for the treatment of cns disorders
06/07/2007US20070129555 N,N'-Di(1-naphthyl)-N,N'-diphenyl-2,6-diaminodibenzodioxin; organic electroelement hole-transporting layer, light-emitting material, a host materialor dopant in the light-emitting layer,a hole-blocking layer, an electron-transporting layer;high luminous efficiency; high heat resistance; durability
06/07/2007US20070129548 Physiochemical properties; stability; medicinal properties; and good processing properties; osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, bone fracture, bone damage following bone reconstructive surgery, sarcopenia, frailty, aging skin, male hypogonadism
06/07/2007US20070129397 Ester derivatives
06/07/2007US20070129382 Crf receptor antagonists, their preparations, their pharmaceutical composition, and their uses
06/07/2007US20070129374 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome
06/07/2007US20070129365 6-Substituted pyridoindolone derivatives, production and therapeutic use thereof
06/07/2007US20070129364 Pyrrolopyridine kinase inhibiting compounds
06/07/2007US20070129362 N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role
06/07/2007US20070129345 Lactam compounds and methods of using the same
06/07/2007CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007CA2632284A1 3-amino-2-arylpropyl azaindoles and uses thereof
06/07/2007CA2632227A1 5-(arylsulfonyl)-pyrazolopiperidines
06/07/2007CA2631259A1 Improved method of preparation for imidazolepyridines
06/07/2007CA2630511A1 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors
06/07/2007CA2630410A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
06/07/2007CA2629962A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/06/2007EP1792903A1 Composition for the dyeing of keratin fibres comprising at least one cationic 3-amino-pyrazolopyridine derivative
06/06/2007EP1792902A1 Processes for preparation of 5-(6-quinazolinyl)-furan-2-carbaldehydes
06/06/2007EP1792606A1 Composition for dyeing keratinic fibers comprising at least one derivative of 3-amino pyrazolopyridine
06/06/2007EP1791843A2 Monocyclic anilide spirolactam cgrp receptor antagonists
06/06/2007EP1791842A1 Process for the preparation of 6, 8-substituted `1, 7 naphthpyridin derivatives by reacting the 8-halo-`1, 7 naphthpyridin-derivate with an organic boronic acid derivatives and intermadiates of this process
06/06/2007EP1791841A1 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity
06/06/2007EP1791840A1 Substituted bicyclic imidazo-3-ylamine compounds
06/06/2007EP1791839A1 PREPARATION OF 9-HYDROXY-3- (2-HYDROXYETHYL) -2-METHYL-4H-PYRID0[1, 2-a]PYRIMIDIN-4-ONE AND CRYSTALS THEREOF
06/06/2007EP1641796B1 5ht2c receptor agonists for the treatment of diabetes and obesity
06/06/2007EP1613313B1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5]-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
06/06/2007EP1427287B1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds
06/06/2007EP1423389B1 Pyrazolo-pyridines for the treatment of herpes infections
06/06/2007CN1977029A Fluorescent quinacridones
06/06/2007CN1976932A Fused quinoline derivative and use thereof
06/06/2007CN1976931A Beta-carbolines useful for treating inflammatory disease
06/06/2007CN1976930A 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents
06/06/2007CN1976929A 咪唑并吡啶化合物 Imidazopyridine compound
06/06/2007CN1976915A Hiv整合酶抑制剂 Hiv integrase inhibitors
06/06/2007CN1976907A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
06/06/2007CN1976904A Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
06/06/2007CN1976705A 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia
06/06/2007CN1974574A Novel tricyclic spiropiperidines or spiropyrrolidines
06/06/2007CN1319975C Camptothecin analogs and methods of preparation thereof
06/06/2007CN1319973C Piperidine derivatives
06/06/2007CN1319971C Camptothecine derivatives and their use
06/06/2007CN1319970C Camptothecin derivative used as anti-tumor agent and preparation method thereof
06/06/2007CN1319969C Fungicides
06/06/2007CN1319968C Compositions useful as inhibitors of GSK-3
06/06/2007CA2630357A1 Pyrimidine-2,4-diamines and their uses
06/05/2007USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists
06/05/2007USRE39679 Substituted heterocycle fused gamma-carbolines
06/05/2007US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders
06/05/2007US7226930 Phosphodiesterase 4 inhibitors
06/05/2007US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents
06/05/2007US7226926 8-fluoroimidazo 1,2-a pyridine derivatives as ligands for GABA receptors
06/05/2007US7226918 DNA-PK inhibitors
06/05/2007CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
05/2007
05/31/2007WO2007062342A1 Heterocyclic cetp inhibitors
05/31/2007WO2007062175A2 Spiro-substituted tricyclic heterocycles cxcr3 antagonists
05/31/2007WO2007061978A1 Spirocyclic compounds as hdac inhibitors
05/31/2007WO2007061880A1 Spirocyclic compounds as hdac inhibitors
05/31/2007WO2007060821A1 Bicyclic cinnamide compound
05/31/2007WO2007060318A1 Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same
05/31/2007WO2007060198A1 Pyrazoloisoquinoline derivatives
05/31/2007WO2007060028A1 Napthyridine compounds as rock inhibitors
05/31/2007WO2007059608A1 Compositions and methods for modulating gated ion channels
05/31/2007WO2007042660A3 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof
05/31/2007WO2007041052A3 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
05/31/2007WO2007040438A3 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders
05/31/2007WO2007039740A3 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders
05/31/2007WO2007037534A9 2-heteroaryl-substituted indole derivative
05/31/2007WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same
05/31/2007WO2007024294A3 Certain substituted ureas, as modulators of kinase activity
05/31/2007WO2007021795A3 Compounds and compositions as protein kinase inhibitors